Menu

Call Us

Map
  1. Enquire Now

Enquire Now

Close

Search

Test Name Test Code Specimen Schedule TAT Division
AKT1 Mutation Analysis (E17K) MG3004 5 ml Blood or 3 ml Bone marrow in K2 EDTA Tube (LCT) Tue 7 days Molecular Genetics
AneuFiSH-5 Markers Chromosomal 13, 18, 21, X, Y Aneuploidy Screen (VB) CG2063 5 ml Venous Blood Sod. Heparin Tube (GCT) Daily 7 days Cytogenetics
BRAF Target Exon Analysis (Exon 11 & 15) MG3011 ST: FFPE or Tumor Tissue or FNA; HC: 5 ml Blood or 3 ml Bone marrow Daily 7 days Molecular Genetics
BRAF V600E Mutation Analysis MG3012 ST: FFPE or Tumor Tissue or FNA; HC: 5 ml Blood or 3 ml Bone marrow Daily 7 days Molecular Genetics
Calreticulin (CALR) Mutation Analysis MG3013 4 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Daily 8 days Molecular Genetics
CEBPA Mutation Analysis MG3014 5 ml Blood or 3 ml Bone marrow in EDTA Vacut. (PCT) Mon 10 days Molecular Genetics
Chromosomal Analysis - Karyotyping (BM) CG2018 2 ml Bone Marrow in Sod. Heparin Tube (GCT) Daily 21 days Cytogenetics
Chromosomal Analysis - Karyotyping (Hematological Cancers) CG2020 5-10 mL blood in Sod.Heparin Tube (GCT) Daily 15 days Cytogenetics
Chromosomal Analysis - Karyotyping (VB) CG2021 5 mL Venous blood in Sod. Heparin Tube (GCT) Daily 15 days Cytogenetics
Chromosomal Analysis - Karyotyping, Couples (VB) CG2022 5 mL Venous blood in Sod. Heparin Tube (GCT) Daily 15 days Cytogenetics
Chromosomal Analysis HR Karyotyping (High Resolution Banding) CG2023 5 mL Blood Sod.Heparin Tube (GCT) Daily 21 days Cytogenetics
Chromosomal Analysis, Karyotyping with reflex FISH (POC) CG2024 Products of Conception (POC) in Sterile Specimen Container (SSC) having Saline+5 drops gentamycin Daily 21 days Cytogenetics
Chromosomal Breakage Analysis CG2025 5 mL Blood Sod. Heparin Tube (GCT) Daily 21 days Cytogenetics
CSF3R Mutation Analysis MG3129 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] Daily 7 days Molecular Genetics
CTNNB1 Mutation Analysis MG3128 Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] Daily 7 days Molecular Genetics
DPD Gene Mutation for 5-Fluorouracil Toxicity Test (DPYD IVS14+1G>A) MG3021 5 ml Blood K2/K3 EDTA Tube (LCT) Daily 7 days Molecular Genetics
EGFR Target Exons Sequencing (Exon 18, 19, 20, & 21) MG3022 Tumor Tissue or FFPE Block or FNA Daily 5 days Molecular Genetics
Factor V Leiden Mutation Analysis (FVL-R506Q) MG3024 5 ml Blood in K2/K3 EDTA Tube (LCT) Daily 7 days Molecular Genetics
FIP1L1-PDGFR-A Gene Rearrangement PCR MG3096 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] Sat 15 days Molecular Genetics
FiSH - Sex Mismatch X, Y Chromosome (Post BMT) CG2030 2 ml Bone Marrow Sod. Heparin Tube (GCT) Daily 7 days Cytogenetics
FLT3 Mutation Analysis (ITD & D835Y) MG3023 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Wed,Sat 5 days Molecular Genetics
GNAS Mutation Analysis (Codon 201 & 227) Exon 8 & 9 MG3029 FFPE OR Fresh tumor tissue Daily 7 days Molecular Genetics
HmLH-1 & HMSH-2 (Repair Genes) Molecular Analysis MG3028 5ml Blood in K2/K3 EDTA Tube (LCT) Daily 10 days Molecular Genetics
HRAS Mutation Analysis MG3044 5 ml Blood in K2/K3 EDTA Tube (LCT) Daily 7 days Molecular Genetics
IDH1 & IDH2 Target Mutation Analysis MG3047 FFPE Block or Tumor Tissue/ 5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) Daily 10 days Molecular Genetics
Imatinib Resistance Mutation Analysis (IRMA) MG3048 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Fri 7 days Molecular Genetics
Inv 16 - t(16-16) (p13q22) Gene Rearrangement Qualitative PCR MG3095 3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] Wed, Sat 7 days Molecular Genetics
JAK2 Exon 12 Sequence Analysis MG3049 5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) Daily 7 days Molecular Genetics
JAK2 Target Exons Sequence Analysis MG3050 5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) Daily 10 days Molecular Genetics
JAK2 V617F Mutation Analysis MG3100 5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) Daily 7 days Molecular Genetics
KIT Exon 17 Mutation Analysis MG3126 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] Daily 7 days Molecular Genetics
KRAS One Mutation Analysis MG3053 Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] Daily 7 days Molecular Genetics
KRAS Target Exons Screening MG3051 Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] Tue,Fri 10 days Molecular Genetics
KRAS Two Mutation Analysis MG3052 Daily 7 days 7 days Molecular Genetics
MPL1 Mutation Analysis (Myeloproliferative Leukemia) MG3054 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Daily 7 days Molecular Genetics
Nonsyndromic Hearing loss Mutation Analysis (Connexin-26) MG3120 5ml Blood in K2/K3 EDTA Tube (LCT) Daily 15 days Molecular Genetics
NRAS Target Exon Sequence Analysis MG3058 Tumor Tissue or FFPE Block Mon 7 days Molecular Genetics
OncoFiSH - 7q deletion Analysis; (7q22;7q36) MDS & AML CG2048 5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) Daily 7 days Cytogenetics
OncoFiSH - ALK Gene Rearrangement CG2049 FFPE (Formalin Fixed Paraffin Embedded) Tissue Block Daily 12 days Cytogenetics
OncoFiSH - ATM Deletion; del(11) (q22.3) (NHL) CG2066 5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) Mon, Thu 7 days Cytogenetics
OncoFiSH - BCR-ABL1; t(9;22)(q34;q11.2) (CML) CG2050 5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) Daily 7 days Cytogenetics
OncoFiSH - cMYC Ampliciation CG2070 5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT); FFPE Block in Sterile Container Daily 7 days Cytogenetics
OncoFiSH - EGFR Gene Amplification CG2051 FFPE (Formalin Fixed Paraffin Embedded) Tissue Block Daily 10 days Cytogenetics
OncoFiSH - ERBB2 (HER-2/neu) Gene Amplification (Breast Cancer) CG2052 Fresh Tumor tissue, FNA, FFPE (Paraffin Embedded Tissue Blocks) Wed, Sat 10 days Cytogenetics
OncoFiSH - ETV6-RUNX1 (TEL-AML1); t(12;21) (p13;q22) CG2067 5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) Mon, Thu 7 days Cytogenetics
OncoFiSH - FGFR3-IGH Fusion; t(4;14)(p16;q32) (NHL) CG2054 3 ml Bone Marrow or 5 ml Blood Sod. Heparin Tube (GCT) Mon, Thu 7 days Cytogenetics
OncoFiSH - IGH Rearrangement; 14q32.3 (ALL / AML) CG2055 5 ml Blood Sod. Heparin Tube (GCT) Mon, Thu 7 days Cytogenetics
OncoFiSH - IGH-CCND1 Fusion; t(11;14) Mantle Cell Lymphoma (MCL) CG2056 3 ml Blood In Sodium Heparin Vacutainer Daily 7 days Cytogenetics
OncoFiSH - IGH-MYC Dual Fusion t(8;14) (Burkitt\'s Lymphoma) CG2057 ST: FFPE or Tumor Tissue or FNA; HC: 5 ml Blood or 3 ml Bone marrow in Heparin Tube (GCT) Mon, Thu 7 days Cytogenetics
OncoFiSH - Inv (16) - CBFB Inversion; t(16;16) (p13;q22) (AML) CG2058 5 ml Blood Sod. Heparin Tube (GCT) Mon, Thu 6 days Cytogenetics
OncoFiSH - KMT2A (MLL) Break-apart Analysis; 11q23 (AML & ALL) CG2059 5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) Mon, Thu 7 days Cytogenetics
OncoFiSH - MYC Break-apart Analysis; 8q24 (B-cell malignancies) CG2060 5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT); FFPE Block in Sterile Container Daily 7 days Cytogenetics
OncoFiSH - PML-RARA; t(15;17) (q22;q21.1) (AML) CG2064 5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) Daily 7 days Cytogenetics
OncoFiSH - RB1-LAMP; 13q34 Deletion CG2061 5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) Mon, Thu 7 days Cytogenetics
OncoFiSH - RUNX1T1-RUNX1 (ETO-AML1); t(8;21) (AML) CG2065 5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) Daily 7 days Cytogenetics
OncoFiSH - TP53 Deletion ; 17p13 Deletion (CLL) CG2062 5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) Mon, Thu 7 days Cytogenetics
OncoFiSH ALK1-ROS1 Rearrangement (FISH for Non Small Cell Lung Cancer-NSCLC) CG2053 FFPE Block; Fresh Tumor Tissue in Normal Saline; FNA on Slide Daily 12 days Cytogenetics
PDGFR Alpha Gene Rearrangement; 4q12 CG2068 5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) Daily 8 days Cytogenetics
PDGFR Beta Gene Rearrangement; 5q33 CG2069 5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) Daily 8 days Cytogenetics
PDGFRA Target Exon Sequence Analysis MG3127 5 ml Blood or 3 ml Bone marrow in EDTA Vacut. (PCT) or FFPE or Tumor Tissue or FNA Daily 7 days Molecular Genetics
PDGFRA Target Exons Sequence Analysis MG3060 Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] Daily 10 days Molecular Genetics
PIK3CA Target Mutation Analysis MG3061 Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] Daily 7 days Molecular Genetics
Platinum Drug Response Genetic Test (GSTP1, XRCC1, ERCC2) MG3062 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Daily 7 days Molecular Genetics
RET High Risk Mutation (Exon 10 &11) MG3064 FFPE or Tumor Tissue or FNA; 5ml Blood for Family Screening Daily 7 days Molecular Genetics
t(11;19) (q23;p13.3); (MLL-ENL), Qualitative PCR MG3091 3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] Wed, Sat 5 days Molecular Genetics
t(12;21) (p13;q22); ETV6-RUNX1(TEL-AML1), Qualitative PCR MG3092 3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] Wed, Sat 5 days Molecular Genetics
t(15;17) (q22;q12) PML-RARA Qualitative PCR MG3093 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Tue, Thu, Sat 3 days Molecular Genetics
t(15;17) (q22;q12) PML-RARA Quantitative PCR MG3094 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Tue, Thu, Sat 5 days Molecular Genetics
t(1;19) (q23;p13.3); TCF3-PBX1 (E2A-PBX1), Qualitative PCR MG3080 3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] Wed, Sat 5 days Molecular Genetics
t(4;11) (q21;q23); (MLL-AF4), Qualitative PCR MG3081 3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] Wed, Sat 5 days Molecular Genetics
t(5;12) ; PDGFRB-ETV6 Gene Rearrangement - PCR MG3082 5ml Blood / 2ml Bone Marrow in K2/K3 EDTA Tube (LCT) Daily 7 days Molecular Genetics
t(8;21) ; AML1-ETO Qualitative PCR MG3084 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Wed, Sat 5 days Molecular Genetics
t(9:22) ; BCR-ABL Qualitative PCR MG3085 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Tue, Thu, Sat 3 days Molecular Genetics
t(9:22) ; BCR-ABL Quantitative (IS-International Scale) MG3086 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Tue, Thu, Sat 5 days Molecular Genetics
t(9;11) (p21-22;q23); (MLL-AF9), Qualitative PCR MG3087 3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] Wed, Sat 5 days Molecular Genetics
Tamoxifen Drug Response Test (CYP2D6 Genotype Analysis) MG3079 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Daily 10 days Molecular Genetics
Waldenstrom macroglobulinemia Molecular Analysis MG3130 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] Daily 7 days Molecular Genetics
WT1 Gene Mutation Analysis (Wilm's Tumor) (Exon 7 & 9) MG3098 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) Daily 10 days Molecular Genetics
Copyright © 2018 Genes N Life, All Rights Reserved.